GSK EPS - Earnings per Share 2010-2022 | GSK

GSK annual and quarterly earnings per share history from 2010 to 2022. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • GSK EPS for the quarter ending June 30, 2022 was $0.41, a 57.74% decline year-over-year.
  • GSK EPS for the twelve months ending June 30, 2022 was $2.92, a 1.98% decline year-over-year.
  • GSK 2021 annual EPS was $3.01, a 17.8% decline from 2020.
  • GSK 2020 annual EPS was $3.66, a 23.96% increase from 2019.
  • GSK 2019 annual EPS was $2.96, a 21.45% increase from 2018.
GSK Annual EPS
2021 $3.01
2020 $3.66
2019 $2.96
2018 $2.43
2017 $1.00
2016 $0.63
2015 $6.59
2014 $2.14
2013 $4.34
2012 $3.69
2011 $4.06
2010 $1.29
2009 $4.23
GSK Quarterly EPS
2022-06-30 $0.41
2022-03-31 $1.20
2021-12-31 $0.51
2021-09-30 $0.80
2021-06-30 $0.98
2021-03-31 $0.73
2020-12-31 $0.47
2020-09-30 $0.80
2020-06-30 $1.40
2020-03-31 $1.00
2019-12-31 $0.84
2019-09-30 $0.96
2019-06-30 $0.62
2019-03-31 $0.54
2018-12-31 $0.82
2018-09-30 $0.93
2018-06-30 $0.30
2018-03-31 $0.39
2017-12-31 $-0.35
2017-09-30 $0.80
2017-06-30 $-0.12
2017-03-31 $0.66
2016-12-31 $0.17
2016-09-30 $0.54
2016-06-30 $-0.32
2016-03-31 $0.21
2015-12-31 $-0.28
2015-09-30 $0.43
2015-06-30 $0.11
2015-03-31 $6.30
2014-12-31 $0.80
2014-09-30 $0.34
2014-06-30 $0.58
2014-03-31 $0.58
2013-12-31 $2.05
2013-09-30 $0.80
2013-06-30 $0.81
2013-03-31 $0.76
2012-12-31 $0.71
2012-09-30 $0.91
2012-06-30 $0.99
2012-03-31 $1.06
2011-12-31 $0.98
2011-09-30 $1.08
2011-06-30 $0.88
2011-03-31 $1.19
2010-12-31 $-0.54
2010-09-30 $0.98
2010-06-30 $-0.23
2010-03-31 $1.00
2009-12-31 $1.30
2009-09-30 $1.08
2009-06-30 $1.16
2009-03-31 $0.80
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.851B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.795B 9.21
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.831B 0.00
QIAGEN (QGEN) Netherlands $9.374B 15.70
Ginkgo Bioworks Holdings (DNA) United States $5.569B 0.00
Arcus Biosciences (RCUS) United States $1.888B 36.85
Myovant Sciences (MYOV) United Kingdom $1.723B 0.00
Emergent Biosolutions (EBS) United States $1.047B 6.07
ADC Therapeutics SA (ADCT) Switzerland $0.370B 0.00
Zymeworks (ZYME) Canada $0.356B 0.00
Enzo Biochem (ENZ) United States $0.109B 0.00
Gelesis Holdings (GLS) United States $0.078B 0.00
SQZ Biotechnologies (SQZ) United States $0.067B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00